Multimodal prospective cohort of Parkinsonism
Official title: A Multimodal Prospective Cohort Study of Parkinsonism
Run by Ruijin Hospital · NCT07553845 · Data updated 2026-11-12
This project will try to track disease progression and improve diagnosis using imaging, clinical tests, and biological samples in people with parkinsonism, people with REM sleep behavior disorder, and healthy volunteers over five years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 31 Years to 79 Years |
| Sex | All |
| Enrollment | 640 (estimated) |
| Sponsor | Ruijin Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | May 1, 2024 |
| Main results expected | May 2029 |
| Study ends | May 2029 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT07553845 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Chinese adults aged over 30 and under 80 who can provide informed consent and either meet standard diagnostic criteria for parkinsonism or for RBD, or are healthy controls without neurological disease.
✕Probably not a fit
People outside the 30–80 age range, non-Chinese citizens, those unable to comply with repeated visits or follow-up, or individuals with severe comorbidities or contraindications to imaging are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective observational cohort enrolling 400 participants with parkinsonism, 120 with REM sleep behavior disorder (RBD), and 120 healthy controls with five years of follow-up. Participants will undergo multimodal assessments including neuroimaging, clinical rating scales, blood and other biological samples, cerebral blood flow testing, neurophysiology, tremor analysis, and voice/video recordings. The study aims to characterize longitudinal progression, identify factors linked to conversion from RBD to parkinsonism, and improve differentiation among parkinsonian disorders. All procedures are observational and designed to build biomarkers and diagnostic signatures rather than test an experimental treatment.
Why it matters
Potential benefit: If successful, the work could help clinicians diagnose different parkinsonian disorders earlier and predict which people with RBD are likely to develop parkinsonism.
How similar studies have gone: Similar longitudinal multimodal cohort studies in Parkinson's disease and RBD have shown some success in identifying potential biomarkers and predictors of conversion, though robust, universally accepted diagnostic markers are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For participants with rapid eye movement sleep behavior disorder: * Meets the diagnostic criteria for rapid eye movement sleep behavior disorder established by the American Academy of Sleep Medicine * Chinese citizen * Age \>30 years and \<80 years * Able to understand the study, show good compliance, and provide written informed consent personally or through a legal representative For participants with Parkinsonism: * Meets the diagnostic criteria for Parkinsonism established by the International Parkinson and Movement Disorder Society * Chinese citizen * Age \>30 years and \<80 years * Able to understand the study, show good compliance, and provide written informed consent personally or through a legal representative For healthy controls: * No neurodegenerative disease, no history of head trauma or head surgery, no history of stroke, epilepsy, tumor, or psychiatric disease * No metal implants or cardiac pacemaker * No severe chronic disease or severe hepatic or renal insufficiency * Chinese citizen * Age \>30 years and \<80 years * Education level of primary school or above * Able to understand the study, show good compliance, and provide written informed consent personally or through a legal representative Exclusion Criteria: * Significant cognitive impairment (MMSE ≤23) * Unable to sign the informed consent form or unable to complete study procedures for other reasons * Any other condition that, in the opinion of the investigator, makes the participant unsuitable for this study
Where it's running
-
Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China Recruiting
Study contacts
- Study coordinator: Jun Liu, Professor
- Email: lj11128@rjh.com.cn
- Phone: +86-021-64370045
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Early PD signals in people with REM sleep behavior disorder
This study tests whether people with REM sleep behavior disorder show early signs of Parkinson’s disease before classic symptoms appear.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Acute intermittent hypercapnia-based interventions for upper airway and axial control in Parkinsonism
This randomized pilot study tests whether a single session of acute intermittent hypercapnic hypoxia or hypercapnic normoxia can improve upper airway and axial motor function in adults with Parkinsonism.
-
Unmet needs of people with isolated REM sleep behavior disorder and their partners
This project asks people with isolated REM sleep behavior disorder (iRBD) and their significant others about their informational, emotional, and practical needs using online questionnaires.
-
Causes and outcomes of freezing of gait in Parkinsonian conditions
This registry will collect long-term clinical, gait, and video data from adults with freezing of gait or related parkinsonian conditions to see if different causes lead to distinct symptoms, walking patterns, falls, and disease progression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.